Bioharvest Sciences (BHST) Consolidated Net Income (2023 - 2025)

Bioharvest Sciences' Consolidated Net Income history runs 3 years deep, the most recent figure standing at -$2.1 million for Q4 2025.

• On a quarterly basis, Consolidated Net Income rose 30.39% year-over-year to -$2.1 million in Q4 2025; TTM through Dec 2025 was -$11.0 million, a 14.89% increase from a year earlier, with the FY2025 full-year figure at -$11.0 million, up 14.84% from the prior year.
• Consolidated Net Income rose to -$2.1 million in Q4 2025 per BHST's latest filing, from -$2.5 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at $2.8 million in Q2 2023 and bottomed at -$17.9 million in Q4 2023.
• The 3-year median for Consolidated Net Income is -$2.5 million (2025), against an average of -$3.4 million.
• Across the five-year window, Consolidated Net Income jumped 83.52% in 2024 and slumped 493.89% in 2025, its largest moves.
• Year by year, Consolidated Net Income stood at -$17.9 million in 2023, then jumped by 83.52% to -$2.9 million in 2024, then surged by 30.39% to -$2.1 million in 2025.
• Per Business Quant, the three latest BHST Consolidated Net Income figures stand at -$2.1 million (Q4 2025), -$2.5 million (Q3 2025), and -$4.1 million (Q2 2025).